Bronchipret® film-coated tablets exert potent anti-inflammatory activity in a rat model of bronchoalveolitis

A fixed combination of thyme and primula extract (Bronchipret® film-coated tablets [BRO]) is clinically used for the treatment of acute bronchitis. Anti-inflammatory properties are expected to substantially contribute to its efficacy in patients. We aimed to provide better understanding of the therapeutic potential of BRO on inflammatory key parameters using an in vivo model of LPS-induced bronchoalveolitis.